MedPath

IRINOTECAN

IRINOTECAN

Discontinued
DIN Number

02410419

Drug Class

Human

Market Date

Mar 7, 2014

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02410419
AIG Number0132910001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01CE02 IRINOTECAN
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

IRINOTECAN HYDROCHLORIDEActive
Strength: 20 MG / ML
Monograph: IRINOTECAN HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.